ATXN3 and Machado-Joseph disease: In an antisense oligonucleotide-based exon skipping approach in MJD patient-derived fibroblasts, the removal of two exons of Atx3 ablated the main recognition sites for calpains and caspases of Atx3 and blocked the formation of potentially toxic polyQ-containing fragments.